OTC paracetamol is for short term use

04 March 2015

Return to Media Release Index

4 March 2015 - The Australian Self Medication Industry (ASMI) confirmed that over-the-counter (OTC) paracetamol is for short term use and has a well-known safety profile, when taken at the recommended dose.

ASMI Regulatory and Scientific Affairs Director Steve Scarff said: "Worldwide, paracetamol has a long history of use and a well-established safety profile. It has been available in Australia for many years, but like all medicines it must be taken only as directed.

"The recommended paracetamol dose for adults and children 12 years and over is 500 to 1000 mg every four to six hours as necessary, with a maximum of 4000 mg in any 24 hour period. 1

"Consumers who require pain relief for longer than a few days should consult with their doctor.  "Like any medicine, it is important that consumers adhere to approved doses and warning statements on the pack. "Consumers who have concerns about their medicines should seek advice from a healthcare professional," Mr Scarff added.

-ENDS-
About ASMI: The Australian Self Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines (CM). ASMI members make up 85 per cent of the $4bn Non-Prescription Medicines market. Membership totals 50 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to advance consumer health through responsible self-care. This means driving a viable and responsible industry and empowering the consumer with evidence-based products and information with the aim of improving health and wellbeing. To find out more about ASMI or how to become an ASMI member, please visit (www.asmi.com.au).

References:
1. Australian Government: Department of Health and Ageing. Therapeutics Goods Administration. Recommended paracetamol doses. Available at http://www.tga.gov.au/consumers/information-paracetamol-doses.htm
For more information or to arrange a media interview, please contact:
Marie Kelly-Davies
Communications Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: marie@asmi.com.au